New CRISPR approach could improve gene and cell therapies
Biomedical engineers at Duke are developing a new CRISPR system designed to alter the epigenome they believe could address some of the shortcomings of CRISPR-Cas9 and be used to perform many different genome engineering tasks simultaneously.